Study Suggests Prostate Cancer Patients Could Produce Antibodies Against Their Own Diseased Cells

Study Suggests Prostate Cancer Patients Could Produce Antibodies Against Their Own Diseased Cells
Researchers at Philadelphia’s Wistar Institute have developed a method that delivers synthetic DNA coding for anti-cancer antibodies to cancer patients, allowing for sustained production of these therapeutic antibodies in a patient’s bloodstream without multiple injections. The team described using the technology to produce antibodies that bind to PSMA, a prostate cancer protein. This attracted specialized immune cells to the

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *